PLAY.CARE

Dates:

01/05/2017 to 30/04/2019

Overview and Aims:

To clinically validate the predictive value of the Play.Care assessement for autism for medical market entry and uptake with Phase 3 Diagnostic Clinical Trials set within a multi-site study of children already diagnosed with ASD in the United Kingdom and Sweden.

Consortium Website:

• https://www.strath.ac.uk/research/innovationinautism/projectscollaborations/ 

Project Partners:

• University of Strathclyde (Consortium Lead)
• University of Aberdeen
• University of Glasgow
• University of Gothenburg

Funder:

• Horizon 2020 SME Instrument to Harimata - https://ec.europa.eu/programmes/horizon2020/en/what-horizon-2020

Protocol Papers:

Millar L, McConnachie A, Minnis H, Wilson P, Thompson L, Anzulewicz A, Sobota K, Rowe P, Gillberg C, Delafield-Butt J. Phase 3 diagnostic evaluation of a smart tablet serious game to identify autism in 760 children 3–5 years old in Sweden and the United Kingdom. BMJ Open 2019;9:e026226. doi: 10.1136/bmjopen-2018-026226